Literature DB >> 15068178

Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum.

Mari Yoshida1.   

Abstract

Amyotrophic lateral sclerosis with dementia (ALS-D) is a non-Alzheimer-type dementia characterized by both frontotemporal degeneration and motor neuron disease and marked by ubiquitin-positive, tau- and alpha-synuclein-negative intraneuronal inclusions and dystrophic neurites. New neuropathological diagnostic criteria for ALS-D are proposed on the basis of the present investigation of 28 autopsy cases. Clinical features included those of typical ALS-D, primary lateral sclerosis, atypical ALS with frontotemporal atrophy and atypical Pick's disease without Pick's bodies. Macroscopically anterior frontotemporal atrophy was observed involving or not involving the precentral gyrus. Microscopically non-specific neuronal loss and gliosis with spongiosis were seen, particularly in superficial layers II and III of the frontotemporal cortices. Diffuse fibrous gliosis was seen in the frontotemporal white matter. The substantia nigra and amygdala showed neuronal loss and gliosis. In all 28 cases, degeneration of both the lower and upper motor neuron systems, consistent with classic sporadic ALS, was present. The distribution and degree of degenerative frontotemporal lesions and motor neuron disturbance were of various patterns. Ubiquitin-positive and tau- and alpha-synuclein negative intraneuronal inclusions and dystrophic neurites in extramotor cortices were observed in all cases. Furthermore, ubiquitin-positive inclusions in lower motor neurons were found in all cases. The distribution pattern and density differed between neuronal inclusions and dystrophic neurites and correlated with clinicopathological phenotypes. Therefore, the ALS-D spectrum may be broader than that previously recognized, extending to primary lateral sclerosis, atypical ALS and to atypical Pick's disease without Pick bodies. Further investigation is needed to determine the characteristics of the ubiquitinated component in ALS-D.

Entities:  

Mesh:

Year:  2004        PMID: 15068178     DOI: 10.1111/j.1440-1789.2003.00544.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  22 in total

1.  Diffusion tensor tract-specific analysis of the uncinate fasciculus in patients with amyotrophic lateral sclerosis.

Authors:  Kanako Sato; Shigeki Aoki; Nobue K Iwata; Yoshitaka Masutani; Takeyuki Watadani; Yasuhiro Nakata; Mariko Yoshida; Yasuo Terao; Osamu Abe; Kuni Ohtomo; Shoji Tsuji
Journal:  Neuroradiology       Date:  2010-02-20       Impact factor: 2.804

2.  Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; David J Libon; Jon B Toledo; Sharon X Xie; Leo McCluskey; Lauren Elman; Felix Geser; Virginia M Y Lee; Murray Grossman; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2012-01-01       Impact factor: 17.088

3.  Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability.

Authors:  F Agosta; E Pagani; M A Rocca; D Caputo; M Perini; F Salvi; A Prelle; M Filippi
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

Review 4.  Frontotemporal dementia: a bridge between dementia and neuromuscular disease.

Authors:  Adeline S L Ng; Rosa Rademakers; Bruce L Miller
Journal:  Ann N Y Acad Sci       Date:  2014-12-30       Impact factor: 5.691

Review 5.  The neuropathological signature of bulbar-onset ALS: A systematic review.

Authors:  S Shellikeri; V Karthikeyan; R Martino; S E Black; L Zinman; J Keith; Y Yunusova
Journal:  Neurosci Biobehav Rev       Date:  2017-02-02       Impact factor: 8.989

6.  Frontotemporal dementia: clinicopathological correlations.

Authors:  Mark S Forman; Jennifer Farmer; Julene K Johnson; Christopher M Clark; Steven E Arnold; H Branch Coslett; Anjan Chatterjee; Howard I Hurtig; Jason H Karlawish; Howard J Rosen; Vivianna Van Deerlin; Virginia M-Y Lee; Bruce L Miller; John Q Trojanowski; Murray Grossman
Journal:  Ann Neurol       Date:  2006-06       Impact factor: 10.422

7.  Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis: a high-field proton MR spectroscopy study.

Authors:  U Usman; C Choi; R Camicioli; P Seres; M Lynch; R Sekhon; W Johnston; S Kalra
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-21       Impact factor: 3.825

8.  Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis.

Authors:  D M Mezzapesa; A Ceccarelli; F Dicuonzo; A Carella; M F De Caro; M Lopez; V Samarelli; P Livrea; I L Simone
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

9.  A case study of an emerging visual artist with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Anli Liu; Kelly Werner; Subhojit Roy; John Q Trojanowski; Ursula Morgan-Kane; Bruce L Miller; Katherine P Rankin
Journal:  Neurocase       Date:  2009-06       Impact factor: 0.881

10.  Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS.

Authors:  Federica Agosta; Sebastiano Galantucci; Nilo Riva; Adriano Chiò; Stefano Messina; Sandro Iannaccone; Andrea Calvo; Vincenzo Silani; Massimiliano Copetti; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2013-04-30       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.